Načítá se...
Rosiglitazone Reversal of Tg2576 Cognitive Deficits is Independent of Peripheral Gluco-Regulatory Status
Converging lines of evidence associate gluco-regulatory abnormalities and peroxisome-proliferator-activated receptor (PPAR) gamma function with increased risk for Alzheimer’s disease (AD). In this study, we used the Tg2576 AD mouse model to test the hypothesis that cognitive improvement following on...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2010
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2975872/ https://ncbi.nlm.nih.gov/pubmed/20709114 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbr.2010.08.002 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|